| |
|
|
|
Fennec Pharmaceuticals Inc.  
|
|
4.87 0.07 (0.01%) |
09-13 15:59 |
|
Open: |
4.81 |
Pre close: |
4.77 |
Target:
|
5.85
|
|
High: |
4.96 |
Low: |
4.76 |
Resistance:
|
5.01
5.85
|
|
Volume: |
34,707 |
Market Cap: |
99M |
Support:
|
4.33
3.91
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.77
 |
MACD |
MACD(12,26):
|
0.13 |
|
MA(20): |
4.49 |
Signal(12,26,9): |
0.09 |
|
MA(100): |
4.19 |
Stochastic Oscillator |
%K(14,3):
|
82.12  |
|
MA(250): |
5.68 |
%D(3): |
84.87 |
|
Average Volume(K) |
3-Month: |
7000
|
52-Week |
High:
|
8.74 |
|
10-Days: |
1860 |
Low: |
3.26 |
|
RSI |
RSI(14):
|
65.22 |
Change(%): |
-42.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.669 |
Return on Equity (ttm) |
-63.3 |
Shares Out. (M) |
19.90 |
|
EPS Est. Current Year |
-0.230 |
Return on Assets (ttm) |
-38.6 |
Shares Float (M) |
11.25 |
|
EPS Est. Next Year |
-0.210 |
PEG Ratio |
0.00 |
% Held by Insiders |
17.41 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
52.04 |
|
Forward EPS |
-0.480 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
170 |
|
Book Value (p.s.) |
0.830 |
EBITDA (p.s.) |
0.000 |
P/E |
-7.28 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
5.87 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-9.76 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-5.10 |
P/CF |
-9.93 |
|
|
|
|
|
|
